NasdaqGM - Nasdaq Real Time Price USD
Sagimet Biosciences Inc. (SGMT)
8.59
-0.02
(-0.29%)
As of 11:06:49 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.71M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MARTINS EDUARDO BRUNO Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 6, 2025 |
| CHAUCHE THIERRY Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 6, 2025 |
| ROZEK ELIZABETH General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 6, 2025 |
| HAPPEL DAVID Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 6, 2025 |
| KEMBLE GEORGE Officer and Director | Sale at price 3.17 per share. | Direct | 74,830 | Jul 23, 2024 |
| MARTINS EDUARDO BRUNO Officer | Sale at price 3.10 per share. | Direct | 25,910 | Jul 19, 2024 |
| KEMBLE GEORGE Officer and Director | Sale at price 3.10 per share. | Direct | 43,605 | Jul 19, 2024 |
| ROZEK ELIZABETH General Counsel | Sale at price 3.10 per share. | Direct | 33,830 | Jul 19, 2024 |
| HAPPEL DAVID Chief Executive Officer | Purchase at price 5.27 per share. | Direct | 63,731 | Mar 26, 2024 |
| HAPPEL DAVID Chief Executive Officer | Purchase at price 4.10 per share. | Direct | 6,560 | Dec 7, 2023 |
| MARTINS EDUARDO BRUNO Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 17, 2023 |
| KEMBLE GEORGE Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 17, 2023 |
| ROZEK ELIZABETH General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 17, 2023 |
| HAPPEL DAVID Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 17, 2023 |
| HAPPEL DAVID Chief Executive Officer | Purchase at price 2.35 per share. | Direct | 1,386 | Nov 16, 2023 |
| KEMBLE GEORGE Officer and Director | Conversion of Exercise of derivative security at price 0.79 per share. | Direct | 4,448 | Sep 7, 2023 |
| KPCB PBD ASSOCIATES, L.L.C. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Jul 18, 2023 |
| NEW ENTERPRISE ASSOCIATES 13, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 16.00 per share. | Indirect | 480,000 | Jul 18, 2023 |
| NEW ENTERPRISE ASSOCIATES 13, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 16.00 per share. | Indirect | 10,592 | Jul 18, 2023 |
| NEW ENTERPRISE ASSOCIATES 13, L.P. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 0.79 per share. | Indirect | 10,653 | Jul 18, 2023 |
| SEIDENBERG BETH C Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Jul 18, 2023 |
| SEIDENBERG BETH C Director | Purchase at price 16.00 per share. | Indirect | 750,000 | Jul 18, 2023 |
| SEIDENBERG BETH C Director | -- | Indirect | -- | Jul 18, 2023 |
| PARSEY MERDAD V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 18, 2023 |
| PARSEY MERDAD V Director | -- | Direct | -- | Jul 18, 2023 |
| WU JINZI JASON Director | -- | Indirect | -- | Jul 18, 2023 |
Related Tickers
URGN UroGen Pharma Ltd.
12.84
+15.87%
KZIA Kazia Therapeutics Limited
9.53
-2.66%
EYEN Eyenovia, Inc.
2.7400
+2.62%
LIMN Liminatus Pharma, Inc.
16.39
-19.31%
PLRZ Polyrizon Ltd.
0.9110
-14.86%
EVGN Evogene Ltd.
1.4822
-2.49%
CVAC CureVac N.V.
5.51
-1.59%
TPST Tempest Therapeutics, Inc.
6.75
-5.06%
MGNX MacroGenics, Inc.
1.5300
-1.29%
IMNN Imunon, Inc.
1.4400
-11.08%